Peranan Mycoplasma genitalium pada Infeksi Menular Seksual

Erico Lemuel Yonathan

doi:10.36452/jkdoktmeditek.v28i2.2264

Authors

Erico Lemuel Yonathan Fakultas Kedokteran, Universitas Kristen Maranatha, Kota Bandung, Indonesia

DOI:

https://doi.org/10.36452/jkdoktmeditek.v28i2.2264

Keywords:

infeksi menular seksual, Mycoplasma genitalium, servisitis

Abstract

Mycoplasma genitalium merupakan suatu mikroorganisme yang berasal dari kelas Mollicutes, tumbuh lambat, dan mampu bereplikasi secara independen. Mycoplasma genitalium telah ditetapkan sebagai salah satu organisme patogen penyebab infeksi menular seksual dalam beberapa dekade terakhir. Transmisi M. genitalium dapat secara genito-genital, ano-genital, namun jarang secara oro-genital. Infeksi M. genitalium dapat bersifat asimptomatik, namun dapat berupa uretritis akut atau kronik, servisitis, dan penyakit radang panggul. Deteksi M. genitalium dengan pewarnaan Gram dan kultur sulit dilakukan, sehingga memerlukan amplifikasi asam nukleat. Penderita infeksi M. genitalium perlu diberikan edukasi menyeluruh mengenai penyakitnya bersama dengan pasangan seksualnya, dan disarankan melakukan abstinensia hubungan seksual selama 14 hari atau hingga gejala sembuh. Terapi infeksi M. genitalium berupa antibiotik seperti makrolida, fluorokuinolon, tetrasiklin, dan pristinamisin. Tingkat resistensi antibiotik yang tinggi merupakan tantangan dalam menangani infeksi M. genitalium. Artikel ini akan merangkum mengenai infeksi M. genitalium, termasuk epidemiologi, gejala klinis, diagnosis, tata laksana, dan tantangan dalam mengobati infeksi M. genitalium, serta peranannya dalam infeksi menular seksual.

References

Gnanadurai R, Fifer H. Mycoplasma genitalium: a review. Microbiology. 2020;166(1):21–9.

Gaydos CA. Mycoplasma genitalium: accurate diagnosis is necessary for adequate treatment. J Infect Dis. 2017;216(Suppl 2):S406–11.

El Novita S. Perkembangan diagnosis dan tata laksana infeksi Mycoplasma genitalium. Cermin Dunia Kedokteran-289. 2020;47(8):719–22.

Couldwell DL, Lewis DA. Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations. Infect Drug Resist. 2015;8:147–61.

Manhart LE, Trent M. Mycoplasma genitalium: a review of current issues and challenges. Contemp Ob Gyn. 2017;62(7):1–6.

Sethi S, Zaman K, Jain N. Mycoplasma genitalium infections: current treatment options and resistance issues. Infect Drug Resist. 2017;10:283–92.

Munoz JL, Goje OJ. Mycoplasma genitalium: an emerging sexually transmitted infection. Scientifica (Cairo). 2016;2016:1–5.

Soni S, Horner P, Rayment M, Pinto-Sander N, Naous N, Parkhouse A, et al. British association for sexual health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019;30(10):938–50.

Harish S. Sexually transmitted infection by Mycoplasma genitalium: a short review . J Ski Sex Transm Dis. 2021;3(1):46–50.

Gesink DC, Mulvad G, Montgomery-andersen R, Poppel U, Montgomery-andersen S, Binzer A, et al. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int J Circumpolar Heal. 2012;71(18203):1–8.

Stewart JD, Webb B, Francis M, Graham M, Korman TM. Should we routinely test for Mycoplasma genitalium when testing for other sexually transmitted infections? Med J Aust. 2020;212(1):30–1.

Ona S, Molina RL, Diouf K. Mycoplasma genitalium: an overlooked sexually transmitted pathogen in women? Infect Dis Obstet Gynecol. 2016;2016:1–9.

Mavedzenge SN, Van Der Pol B, Weiss HA, Kwok C, Mambo F, Chipato T, et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. Aids. 2012;26(5):617–24.

Rasianti R, Puspitosari D, Teja FH, Dharmadji H, 6 nama?, et al. Mycoplasma genitalium infection prevalence in patients with Human Immunodeficiency Virus. Int J Integr Heal Sci. 2014;2(1):30–5.

Zarei O, Rezania S, Mousavi A. Mycoplasma genitalium and cancer: a brief review. Asian Pacific J Cancer Prev. 2013;14(6):3425–8.

Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatology Venereol. 2016;30(10):1650–6.

Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis. 2017;216(Suppl 2):S396–405.

McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog. 2011;7(5):1–10.

Birger R, Saunders J, Estcourt C, Sutton AJ, Mercer CH, Roberts T, et al. Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model. Sci Rep. 2017;7(1):1–13. Diunduh dari http://dx.doi.org/10.1038/s41598-017-16302-8

Cadosch D, Garcia V, Jensen JS, Low N, Althaus CL. Understanding the spread of de novo and transmitted macrolide-resistance in Mycoplasma genitalium. PeerJ. 2020;2020(4):1–16.

Le Roux MC, Mafunise M, De Villiers BE, Ditsele RM. Antimicrobial susceptibility of Mycoplasma genitalium isolates from Pretoria, South Africa in 2012 and 2016. South African J Infect Dis. 2018;33(2):46–9.

Ng KKM, Leung PKL, Cheung TKM. Molecular detection of Mycoplasma genitalium in endocervical swabs and associated rates of macrolide and fluoroquinolone resistance in Hong Kong. Hong Kong Med J. 2020;26(5):390–6.

Anagrius C, Lore B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic. PLoS One. 2013;8(4):1–10.

Maatouk I, Assi M. A case of Mycoplasma genitalium possible resistance in a woman. Int J Women’s Dermatology. 2020;6(2):116–7. Diunduh dari https://doi.org/10.1016/j.ijwd.2019.11.002